<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17488" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Amsler Grid</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Salini</surname>
            <given-names>Baby</given-names>
          </name>
          <aff>Ahalia Foundation Eye Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Baby Salini declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17488.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Wet age-related macular degeneration is a leading cause of severe vision loss in the elderly population, both in the United States and worldwide. Early detection is vital so that treatment can be implemented promptly, in turn increasing the potential for successful prevention of blindness. Affordable, home-monitoring techniques such as usage of an Amsler grid may help decrease the latency between onset of wet age-related macular degeneration and initiation of treatment. This activity describes who is a candidate for a home Amsler grid and reviews how to use the Amsler grid. Additionally, this activity highlights the role of the interprofessional team in helping to identify patients who might benefit from this tool and educate these patients on how to use it.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications for use of an Amsler grid.</p></list-item><list-item><p>Explain how to use an Amsler grid.</p></list-item><list-item><p>Describe how to interpret the results of an Amsler grid session.</p></list-item><list-item><p>Review interprofessional team strategies to improve identification of patients who might benefit from the use of a home Amsler grid and to provide education to these patients.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17488&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17488">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17488.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The Amsler Grid is a square-shaped grid used to detect or monitor metamorphopsia or scotoma involving the central visual field in various disorders of the macula and optic nerve head. Specifically, it is used as an&#x000a0;inexpensive home monitoring device for early detection of metamorphopsia due to wet age-related macular degeneration. Also, it may be used as a macular function test before cataract surgery.</p>
        <p>The grid gets its name from Marc Amsler (1891-1968), a Swiss ophthalmologist, who described the chart in 1947.<xref ref-type="bibr" rid="article-17488.r1">[1]</xref> He was a student of Jules Gonin (1870-1935).&#x000a0;He might have gotten the idea of&#x000a0;the grid from Edmund Landolt (1846-1926), who devised a similar small card with a grid pattern to be kept in the center of the perimeter.<xref ref-type="bibr" rid="article-17488.r1">[1]</xref>&#x000a0;Jacob Hermann Knapp (1832-1911) described&#x000a0;scotoma and metamorphopsia in&#x000a0;traumatic maculopathy&#x000a0;with choroidal rupture using horizontal lines in 1869. Richard Forster (1825-1902)&#x000a0;demonstrated metamorphopsia using a square grid&#x000a0;in 1874.<xref ref-type="bibr" rid="article-17488.r1">[1]</xref></p>
      </sec>
      <sec id="article-17488.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>The location of the fovea is approximately two disc diameters (3 mm on average)&#x000a0;temporal to the temporal margin of the optic disc. The physiological blind spot on the visual field corresponds anatomically with the optic disc. In the visual field, the blind spot is located&#x000a0;usually at 15 degrees temporal to the point of fixation (anatomically corresponding to fovea).<xref ref-type="bibr" rid="article-17488.r2">[2]</xref>&#x000a0;The shape of the blind spot is vertically oval measuring 7.5 degrees vertically and 5.5 degrees horizontally.<xref ref-type="bibr" rid="article-17488.r2">[2]</xref>&#x000a0;Another anatomically important fact is that the density of cones at the center of the fovea is maximum, extrapolated to around 150000 to 180000 cells/mm, which reduces rapidly to 6000 cones/mm at 1.5 mm from the fovea,<xref ref-type="bibr" rid="article-17488.r3">[3]</xref> which leads to the best visual acuity at the fovea.</p>
        <p>The Oxford dictionary defines metamorphopsia as 'defective visual perception in which objects appear distorted in shape, size, etc.' The proposed mechanism of metamorphopsia include<xref ref-type="bibr" rid="article-17488.r4">[4]</xref><xref ref-type="bibr" rid="article-17488.r5">[5]</xref><xref ref-type="bibr" rid="article-17488.r6">[6]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Displacement of photoreceptors causing a defective localization of perceived image</p>
          </list-item>
          <list-item>
            <p>Using optical coherence tomography (OCT), it has been noted that in epiretinal membrane thickening of the inner nuclear layer (INL) is associated with metamorphopsia while inner segment-outer segment junction status affects visual acuity
<list list-type="bullet"><list-item><p>The hypothesis is that 'the structures of horizontal, bipolar, amacrine, and Muller cell bodies, which comprise INL, may change</p></list-item><list-item><p>This inhibits the function of synaptic junctions and lowers photoreceptor sensitivity, causing metamorphopsia</p></list-item><list-item><p>Additionally, thickening of GCL (ganglion cell layer) and INL may induce aberration in the retina, and quality of vision may undergo 'deterioration'</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Other visual processing may be involved in the perception of metamorphopsia; this includes cortical processing, and the details of the stimulus/scene might have a role</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17488.s4" sec-type="Indications">
        <title>Indications</title>
        <p>The Amsler grid is valid in the following scenarios<xref ref-type="bibr" rid="article-17488.r7">[7]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Wet age-related macular degeneration (wAMD) - The choroidal neovascular membrane (CNVM) causes metamorphopsia and new scotoma</p>
          </list-item>
          <list-item>
            <p>Central serous chorioretinopathy&#x000a0;(CSCR) - Causes a central scotoma which may be round or oval depending on the shape of neurosensory retinal detachment</p>
          </list-item>
          <list-item>
            <p>Epiretinal membrane and other vitreoretinal interface diseases, which causes metamorphopsia.</p>
          </list-item>
          <list-item>
            <p>Acute macular neuroretinopathy&#x000a0;- Flower petal-like scotoma is seen corresponding to fundus lesions which become more prominent in near-infrared (NIR) or multicolor imaging</p>
          </list-item>
          <list-item>
            <p>Cystoid macular edema - The distance between the photoreceptors increase due to macular edema, and things appear smaller (micropsia); cystoid macular edema may result from diabetic maculopathy, retinal vein occlusion, intermediate uveitis,&#x000a0;CNVM, and other diseases</p>
          </list-item>
          <list-item>
            <p>Non-arteritic anterior ischemic optic neuropathy- The grid might reveal an altitudinal defect in the visual field</p>
          </list-item>
          <list-item>
            <p>Pituitary tumor - The Amsler grid may be used to demonstrate&#x000a0;bitemporal hemianopia</p>
          </list-item>
          <list-item>
            <p>Hydroxychloroquine retinopathy may cause central scotoma; however, Amsler grid is currently not recommended as a screening tool for hydroxychloroquine retinopathy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17488.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>There is no contraindication to using Amsler grid. There should be a reasonable vision level to discern the lines of the grid. However, the sensitivity to detect wAMD&#x000a0;changes may be low, and the Amsler grid does not replace the need for ophthalmic examination. As the grid&#x000a0;evaluates&#x000a0;only 10 degrees temporal to fixation, the physiological blind spot is not appreciated in Amsler grid. Glaucomatous visual field defects may not be detected in Amsler grid until the disease is advanced and field defect reaches close to fixation.</p>
      </sec>
      <sec id="article-17488.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>The grid measures 10 cm &#x000d7; 10 cm. When used at 33 cm from the eye, the grid can check for changes in a 20&#x000b0; field. This field spans 10&#x000b0; on each side (above, below, and on the left and right side) of the fixation.&#x000a0;</p>
        <p>There are 7&#x000a0;charts of the Amsler Grid each with a dimension of&#x000a0;10 cm &#x000d7; 10 cm.</p>
        <list list-type="order">
          <list-item>
            <p>Chart 1- The lines are white in a black background. There are 20 small squares in each side of the grid. Thus each side of the small squares measures 10cm/20= 5mm. Each small square cast an angle of 20&#x000b0;/20=1&#x000b0; field when the grid is held at 33 cm from the eye.</p>
          </list-item>
          <list-item>
            <p>Chart 2- Four diagonal white lines are placed over the chart 1 to help fixation in an eye with a central scotoma.</p>
          </list-item>
          <list-item>
            <p>Chart 3- It is similar to chart 1, except the fact that there are red (in place of white) lines over a&#x000a0;black background. Red specifically stimulates the long wavelength cones. This chart is to pick up subtle red desaturation in diseases including bitemporal hemianopia in a pituitary tumor, toxic optic neuropathy, and toxic maculopathy.</p>
          </list-item>
          <list-item>
            <p>Chart 4- There is no line. Over a black background, there is a central large round white dot. In other spaces, there are multiple small random white dots. This chart is used to differentiate scotoma from metamorphopsia as there is no form appreciable for distortion.</p>
          </list-item>
          <list-item>
            <p>Chart 5- There is a square with 21 horizontal white lines on black background 5mm apart. A central white dot is present for fixation. It is used to determine any specific meridian of metamorphopsia specifically in patients with reading difficulties.</p>
          </list-item>
          <list-item>
            <p>Chart 6- This is a modification of chart 5. Of the 7 charts, only this chart has black lines on white&#x000a0;background. The central lines are closer than the chart 5, helping to evaluate fine metamorphopsia near fixation.</p>
          </list-item>
          <list-item>
            <p>Chart 7- This is a modification of chart 1. There is a central area&#x000a0;with smaller squares each one subtending 0.5&#x000b0; field. Small scotoma or area of metamorphopsia near the fixation can be demonstrated with this chart.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17488.s7" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>The grid is kept at 33 cm from the eye. The illumination of the chart should be good. Light exposure directly over the eye (in the form of slit-lamp examination, indirect ophthalmoscopy, and others) should&#x000a0;be avoided immediately before using the grid to avoid a photostress effect. The patient wears near correction&#x000a0;if any. Pupils should not be dilated.&#x000a0;The patient&#x000a0;is asked to close one eye. With the open eye through the near glasses, the patient is instructed to look at the central dot of the grid. In patients with poor fixation, the eye should focus at the center of the grid so that all the 4 corners are simultaneously visible. While keeping the eye fixated over the center of the grid, the patient has to appreciate is the lines are parallel or seem distorted (metamorphopsia). Also, he/she should note if&#x000a0;some of the small squares are missing or blurry. The patient should mark the grid with the&#x000a0;area of abnormality so that&#x000a0;it can be compared later for any progression, stabilization, or improvement. If the patient can not see the corners, diseases like glaucoma and retinitis&#x000a0;pigmentosa should&#x000a0;be ruled out. Amsler grid should be checked at least once weekly.</p>
        <p>&#x000a0;Alternative techniques to document metamorphopsia include:</p>
        <list list-type="bullet">
          <list-item>
            <p>M chart<xref ref-type="bibr" rid="article-17488.r8">[8]</xref>&#x000a0;or metamorphopsia chart- There are 19 dotted lines with separation between the dots between 0.2&#x000b0; (fine) to 2&#x000b0; (coarse) visual angles. As the patient sees more coarsely separated dots, the metamorphopsia usually reduces and disappears. The metamorphopsia is quantified by 'the minimum visual angle of the dotted lines needed to cause the metamorphopsia to disappear'. This can measure both horizontal and vertical metamorphopsia. However, the shape and size of the metamorphopsia cannot be quantified using this test.</p>
          </list-item>
          <list-item>
            <p>Preferential hyperacuity perimeter PHP- Hyperacuity or Vernier acuity is a cortically mediated function to detect very subtle misalignments which may be as less as 3-6 seconds of arc.&#x000a0;<xref ref-type="bibr" rid="article-17488.r9">[9]</xref>&#x000a0;It is defined as 'the ability to perceive a difference in the relative spatial localization of 2 or more visual stimuli'.<xref ref-type="bibr" rid="article-17488.r10">[10]</xref>
<list list-type="bullet"><list-item><p>Foresee&#x000a0;Home (Notal Vision, Tel Aviv, Israel) is a type of PHP. It has been approved by the FDA (Food and Drug Administration, USA)&#x000a0; for 'use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration, as an aid in monitoring progression of disease factors causing metamorphopsia including but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.' This device tests the central 14&#x000b0; of the visual field and total 500 data points are tested, 3-5 times each. However, it is not suitable for patients with cognitive decline (Alzheimer's disease) or if the patient can not establish a baseline in 2 attempts.</p></list-item><list-item><p>Macular Computerized Psychophysical Test (MCPT) uses hyperacuity to detect metamorphopsia.<xref ref-type="bibr" rid="article-17488.r11">[11]</xref></p></list-item><list-item><p>PreView PHP (Carl Zeiss Meditec, Dublin, CA)- This device also uses the principles of PHP. In a study, it was concluded that it can 'detect recent-onset CNV resulting from AMD and can differentiate it from an intermediate stage of AMD with high sensitivity and specificity'.<xref ref-type="bibr" rid="article-17488.r10">[10]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Shape discrimination hyperacuity (SDH)- Very minor sinusoidal deviation from circularity is detected by human eyes.<xref ref-type="bibr" rid="article-17488.r12">[12]</xref>&#x000a0;The threshold for SDH is &#x0003c;10 seconds of arc and is not affected by age or reduction of contrast at low radial frequencies.<xref ref-type="bibr" rid="article-17488.r9">[9]</xref> Using this principle, radial shape discrimination testing may be used to detect new onset wet AMD.<xref ref-type="bibr" rid="article-17488.r13">[13]</xref>&#x000a0;Handheld SDH&#x000a0;is available&#x000a0;(myVisionTrack; Vital Art and Science, Inc., Richardson, TX) for smartphones (iOS; Apple, Inc., Cupertino, CA).<xref ref-type="bibr" rid="article-17488.r14">[14]</xref>&#x000a0;It has been cleared by FDA to be used as an Ophthalmic medical device,&#x000a0; 'for the detection and characterization of central three degrees metamorphopsia (visual distortion) in patients with maculopathy, including age-related macular degeneration and diabetic eye disease, and as an aid in monitoring disease factors causing metamorphopsia. It is intended to be used by patients who have the capability to regularly perform a simple self-test at home'. The patient uses the software twice weekly and it notifies the eye care professional in case of any change in visual function.</p>
          </list-item>
          <list-item>
            <p>Differential perimetry<xref ref-type="bibr" rid="article-17488.r15">[15]</xref> - In case of displacement of photoreceptors, the visual field projection changes. This leads to loss of correspondence of the visual field with the normal fellow eye. This can help document metamorphopsia using binocular perimetry with Goldmann perimeter.</p>
          </list-item>
          <list-item>
            <p>Three-dimensional computer-automated threshold Amsler grid test (3D CTAG)- This test has been described by Fink and Sadun&#x000a0;from Doheny Eye Institute, California.<xref ref-type="bibr" rid="article-17488.r16">[16]</xref>&#x000a0;It characterizes the scotoma in 3 dimensions with excellent detail ('location, extent, slope, depth, and shape').<xref ref-type="bibr" rid="article-17488.r16">[16]</xref></p>
          </list-item>
        </list>
        <p>Other techniques/instruments which may be used to document scotoma include-</p>
        <list list-type="bullet">
          <list-item>
            <p>Perimeter- Static (Humphrey field analyzer, the 10-2 protocol for central scotoma) or dynamic (Goldmann perimeter, tangent screen), or both static and kinetic (Octopus)</p>
          </list-item>
          <list-item>
            <p>Microperimetry- This machine checks the visual threshold of a specific area of the retina so that a correlation between structure and function is possible in a pictorial manner on an overlay of the fundus image. It also identifies any preferred retinal loci. The available machines are&#x000a0;Nidek MP-3 (Nidek&#x000a0;Co. Ltd., Aichi, Japan), and Macular Integrity Assessment microperimeter (MAIA, CentreVue, Padova, Italy).<xref ref-type="bibr" rid="article-17488.r17">[17]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17488.s8" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Amsler grid is an important simple tool to detect or monitor macular diseases.</p>
        <p>Metamorphopsia- Macropsia is denoted by the widening of the small squares compared to the nearby small squares. The parallel lines seem to be curved away from each other at this area. In the area of&#x000a0;micropsia, the parallel lines seem to be drawn towards each other.</p>
        <p>Scotoma- Merriam Webster dictionary defines scotoma as 'a spot in the visual field in which vision is absent or deficient.' A scotoma is surrounded by an area of the normal field of vision. A scotoma may be absolute (absent visual recognition of that area in spite of increasing the stimulus intensity) or relative (the stimulus presented at the scotoma becomes visible if stimulus intensity is increased). In Amsler grid, the relative scotoma appears as a veil partially obscuring the smaller squares and may be of different shapes. Such scotoma may be better appreciated if the illumination of the grid is reduced. Scotomas may be positive (something like spot or haze or smoke obscures central vision) or negative (the patient is unaware of scotoma unless tested).</p>
        <p>Amsler grid home monitoring has various limitations including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Suprathreshold stimulus</p>
          </list-item>
          <list-item>
            <p>No monitor for fixation- stability of fixation is not monitored.</p>
          </list-item>
          <list-item>
            <p>No quantification of metamorphopsia</p>
          </list-item>
          <list-item>
            <p>Not interactive</p>
          </list-item>
          <list-item>
            <p>Scotoma detection and mapping may be suboptimal</p>
          </list-item>
          <list-item>
            <p>Need for&#x000a0;good near vision to discern the grids</p>
          </list-item>
          <list-item>
            <p>Poor repeatability of scotoma<xref ref-type="bibr" rid="article-17488.r18">[18]</xref>- Size, shape, and location of the scotoma detected on Amsler grid may not be same if the same patient is re-examined with Amsler grid even within 15 minutes. This may be related to 'perceptual completion phenomenon' which results&#x000a0;from 'a filling in of the missing information when part of an image falls on a blind area of the visual field' which may be cortically mediated.<xref ref-type="bibr" rid="article-17488.r18">[18]</xref><xref ref-type="bibr" rid="article-17488.r19">[19]</xref>&#x000a0;Due to the same phenomenon, the blind spot due to the optic disc is not usually appreciated. It has been&#x000a0;noted that scotoma less than 6 degrees may not be detected by Amsler grid.<xref ref-type="bibr" rid="article-17488.r20">[20]</xref></p>
          </list-item>
          <list-item>
            <p>Low sensitivity for detection of peripheral changes due to the crowding effect of the peripheral lines</p>
          </list-item>
          <list-item>
            <p>Poor compliance</p>
          </list-item>
        </list>
        <p>The modifications of the Amsler chart include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Threshold Amsler chart- The effective luminance of the white on black Amsler Grid may be&#x000a0;lowered by placing a cross polarizing&#x000a0;lens in front of the eye<xref ref-type="bibr" rid="article-17488.r21">[21]</xref> and this may be better in picking up scotoma than the standard Amsler chart.<xref ref-type="bibr" rid="article-17488.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>The sensitivity of the Amsler grid may also be improved with the use of red grids.<xref ref-type="bibr" rid="article-17488.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p>A&#x000a0;Modified Amsler Chart with 'a grid of black lines on a white background measuring 12 &#x000d7; 12 cm with grid squares of 2 &#x000d7; 2 cm' has been reported by Shinoda and colleagues.<xref ref-type="bibr" rid="article-17488.r23">[23]</xref>&#x000a0;There are 6X6 or 36 squares. The patient with metamorphopsia is asked to trace the lines as they see it. The length of all the distorted lines drawn by the patient is measured in milimeters except the outer margin of the chart.</p>
          </list-item>
          <list-item>
            <p>Sine Amsler chart<xref ref-type="bibr" rid="article-17488.r24">[24]</xref>&#x000a0;uses 8 modified Amsler grids with central sine waves instead of lines. The frequency of the sine wave is constant in each chart, but the amplitude is different. The patient is asked to note the amount of metamorphopsia in an Amsler grid. Then he/she is asked to corroborate the magnitude of metamorphopsia to a specific sine Amsler chart</p>
          </list-item>
          <list-item>
            <p>Morphision<xref ref-type="bibr" rid="article-17488.r25">[25]</xref>- It consists of 50 modified Amsler grids in an A5 sized booklet. 'The control plate (1) allows detection and localization of distortion, the second plate (2) identifies the pattern of distortion, and the remaining 48 plates quantify metamorphopsia'.<xref ref-type="bibr" rid="article-17488.r25">[25]</xref>&#x000a0;Various charts consist of sine waves replacing lines, and cushion or barrel-like distortion.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17488.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Appropriate use of the Amsler grid requires an interprofessional team. The nurses and optometrists who&#x000a0;are involved in patient care should be taught how to handle the instrument properly without any damage. Also, the nurses should assist the clinician with giving proper instructions to the patient so that the final result will not be ambiguous. Often patients will use the Amsler grid at home. The nurse should monitor compliance and report to the ophthalmologist or optometrist if the patient is not compliant or inappropriately using the grid. It is also important to not to apply any mydriatic in the eye prior to the test. If the nurse or clinician accidentally uses a mydriatic, the team should be informed of the application and the test rescheduled on a later date. Interprofessional application and education&#x000a0;of patients using&#x000a0;the Amsler grid will result in the best outcomes. [Level V]</p>
      </sec>
      <sec id="article-17488.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17488&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17488">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17488/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17488">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17488.s11">
        <fig id="article-17488.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Amsler Grid, Age-Related Macular Degeneration.
Contributed by National Eye Institute, National Institutes of Health (NIH)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Amsler_grid_-_age-related_macular_degeneration_EC04" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17488.s12">
        <title>References</title>
        <ref id="article-17488.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marmor</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>A brief history of macular grids: from Thomas Reid to Edvard Munch and Marc Amsler.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2000</year>
            <season>Jan-Feb</season>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>343</fpage>
            <page-range>343-53</page-range>
            <pub-id pub-id-type="pmid">10667441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abadi</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Jeffery</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Awareness and filling-in of the human blind spot: linking psychophysics with retinal topography.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2011</year>
            <month>Jan</month>
            <day>25</day>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>541</fpage>
            <page-range>541-8</page-range>
            <pub-id pub-id-type="pmid">20847110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jonas</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Naumann</surname>
                <given-names>GO</given-names>
              </name>
            </person-group>
            <article-title>Count and density of human retinal photoreceptors.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>1992</year>
            <volume>230</volume>
            <issue>6</issue>
            <fpage>505</fpage>
            <page-range>505-10</page-range>
            <pub-id pub-id-type="pmid">1427131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watanabe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arimoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nishi</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Correlation between metamorphopsia and epiretinal membrane optical coherence tomography findings.</article-title>
            <source>Ophthalmology</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>116</volume>
            <issue>9</issue>
            <fpage>1788</fpage>
            <page-range>1788-93</page-range>
            <pub-id pub-id-type="pmid">19643494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okamoto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sugiura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Okamoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hiraoka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Oshika</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Associations between metamorphopsia and foveal microstructure in patients with epiretinal membrane.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2012</year>
            <month>Oct</month>
            <day>03</day>
            <volume>53</volume>
            <issue>11</issue>
            <fpage>6770</fpage>
            <page-range>6770-5</page-range>
            <pub-id pub-id-type="pmid">22969078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiecek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lashkari</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dakin</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Bex</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Novel quantitative assessment of metamorphopsia in maculopathy.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2014</year>
            <month>Nov</month>
            <day>18</day>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>494</fpage>
            <page-range>494-504</page-range>
            <pub-id pub-id-type="pmid">25406293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marmor</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Kellner</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Melles</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Mieler</surname>
                <given-names>WF</given-names>
              </name>
              <collab>American Academy of Ophthalmology</collab>
            </person-group>
            <article-title>Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).</article-title>
            <source>Ophthalmology</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>123</volume>
            <issue>6</issue>
            <fpage>1386</fpage>
            <page-range>1386-94</page-range>
            <pub-id pub-id-type="pmid">26992838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsumoto</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arimura</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Okuyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shimomura</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Quantification of metamorphopsia in patients with epiretinal membranes.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>44</volume>
            <issue>9</issue>
            <fpage>4012</fpage>
            <page-range>4012-6</page-range>
            <pub-id pub-id-type="pmid">12939323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Midena</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vujosevic</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Metamorphopsia: An Overlooked Visual Symptom.</article-title>
            <source>Ophthalmic Res</source>
            <year>2015</year>
            <volume>55</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-36</page-range>
            <pub-id pub-id-type="pmid">26554918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alster</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bressler</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Bressler</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Brimacombe</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Crompton</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Duh</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Gabel</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Heier</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Ip</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Loewenstein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Packo</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Stur</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Toaff</surname>
                <given-names>T</given-names>
              </name>
              <collab>Preferential Hyperacuity Perimetry Research Group</collab>
            </person-group>
            <article-title>Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study.</article-title>
            <source>Ophthalmology</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>112</volume>
            <issue>10</issue>
            <fpage>1758</fpage>
            <page-range>1758-65</page-range>
            <pub-id pub-id-type="pmid">16154198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loewenstein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malach</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leibovitch</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Barak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baruch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Alster</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Rafaeli</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Avni</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Yassur</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration.</article-title>
            <source>Ophthalmology</source>
            <year>2003</year>
            <month>May</month>
            <volume>110</volume>
            <issue>5</issue>
            <fpage>966</fpage>
            <page-range>966-70</page-range>
            <pub-id pub-id-type="pmid">12750099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilkinson</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Habak</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Detection and recognition of radial frequency patterns.</article-title>
            <source>Vision Res</source>
            <year>1998</year>
            <month>Nov</month>
            <volume>38</volume>
            <issue>22</issue>
            <fpage>3555</fpage>
            <page-range>3555-68</page-range>
            <pub-id pub-id-type="pmid">9893789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pitrelli Vazquez</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Harding</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Heimann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Czanner</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Knox</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>Radial shape discrimination testing for new-onset neovascular age-related macular degeneration in at-risk eyes.</article-title>
            <source>PLoS One</source>
            <year>2018</year>
            <volume>13</volume>
            <issue>11</issue>
            <fpage>e0207342</fpage>
            <pub-id pub-id-type="pmid">30408127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>YZ</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>YG</given-names>
              </name>
              <name>
                <surname>Mitzel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Handheld shape discrimination hyperacuity test on a mobile device for remote monitoring of visual function in maculopathy.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2013</year>
            <month>Aug</month>
            <day>13</day>
            <volume>54</volume>
            <issue>8</issue>
            <fpage>5497</fpage>
            <page-range>5497-505</page-range>
            <pub-id pub-id-type="pmid">23860761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jensen</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Larsen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Objective assessment of photoreceptor displacement and metamorphopsia: a study of macular holes.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>116</volume>
            <issue>10</issue>
            <fpage>1303</fpage>
            <page-range>1303-6</page-range>
            <pub-id pub-id-type="pmid">9790627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fink</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sadun</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Three-dimensional computer-automated threshold Amsler grid test.</article-title>
            <source>J Biomed Opt</source>
            <year>2004</year>
            <season>Jan-Feb</season>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>149</fpage>
            <page-range>149-53</page-range>
            <pub-id pub-id-type="pmid">14715067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cassels</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Wild</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Margrain</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Acton</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>The use of microperimetry in assessing visual function in age-related macular degeneration.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2018</year>
            <season>Jan-Feb</season>
            <volume>63</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-55</page-range>
            <pub-id pub-id-type="pmid">28579549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Achard</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Safran</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Duret</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Ragama</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Role of the completion phenomenon in the evaluation of Amsler grid results.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1995</year>
            <month>Sep</month>
            <volume>120</volume>
            <issue>3</issue>
            <fpage>322</fpage>
            <page-range>322-9</page-range>
            <pub-id pub-id-type="pmid">7661204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramachandran</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Gregory</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Perceptual filling in of artificially induced scotomas in human vision.</article-title>
            <source>Nature</source>
            <year>1991</year>
            <month>Apr</month>
            <day>25</day>
            <volume>350</volume>
            <issue>6320</issue>
            <fpage>699</fpage>
            <page-range>699-702</page-range>
            <pub-id pub-id-type="pmid">2023631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schuchard</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Validity and interpretation of Amsler grid reports.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1993</year>
            <month>Jun</month>
            <volume>111</volume>
            <issue>6</issue>
            <fpage>776</fpage>
            <page-range>776-80</page-range>
            <pub-id pub-id-type="pmid">8512478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wall</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sadun</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Threshold Amsler grid testing. Cross-polarizing lenses enhance yield.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1986</year>
            <month>Apr</month>
            <volume>104</volume>
            <issue>4</issue>
            <fpage>520</fpage>
            <page-range>520-3</page-range>
            <pub-id pub-id-type="pmid">3954654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slavin</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>The use of the red Amsler grid and red-green lenses in detecting spurious paracentral visual field defects.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1987</year>
            <month>Mar</month>
            <day>15</day>
            <volume>103</volume>
            <issue>3 Pt 1</issue>
            <fpage>338</fpage>
            <page-range>338-9</page-range>
            <pub-id pub-id-type="pmid">3826248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shinoda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ishida</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kawashima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Matsuzaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Katsura</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>A new method for quantification of metamorphopsia in patients with epiretinal membrane.</article-title>
            <source>Jpn J Ophthalmol</source>
            <year>2000</year>
            <season>Jul-Aug</season>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>424</fpage>
            <page-range>424-7</page-range>
            <pub-id pub-id-type="pmid">10974300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bouwens</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Van Meurs</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Sine Amsler Charts: a new method for the follow-up of metamorphopsia in patients undergoing macular pucker surgery.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>241</volume>
            <issue>2</issue>
            <fpage>89</fpage>
            <page-range>89-93</page-range>
            <pub-id pub-id-type="pmid">12605261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17488.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ugarte</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shunmugam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Laidlaw</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Williamson</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Morphision: a method for subjective evaluation of metamorphopsia in patients with unilateral macular pathology (i.e., full thickness macular hole and epiretinal membrane).</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>61</volume>
            <issue>11</issue>
            <fpage>653</fpage>
            <page-range>653-8</page-range>
            <pub-id pub-id-type="pmid">24008785</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
